Combination therapy in rheumatoid arthritis
39 results
1 - 39
Combination therapy in rheumatoid arthritis 
Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)- Rheumatoid arthritis
- Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
- Adalimumab for treating rheumatoid arthritis
- Short‐term induction glucocorticoids and disease‐modifying anti‐rheumatic drugs (DMARD) therapy for rheumatoid arthritis
- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
- Infliximab for the treatment of rheumatoid arthritis
- Juvenile idiopathic arthritis (juvenile rheumatoid arthritis)
Adding MTX to sulfasalazine better for RA (MASCOT)- Tocilizumab for rheumatoid arthritis
- Anakinra for rheumatoid arthritis
- Herbal therapy for rheumatoid arthritis
- Golimumab for rheumatoid arthritis
- Tocilizumab for rheumatoid arthritis
- RA options: MTX still first-line
- Anakinra for rheumatoid arthritis
- Opioid therapy for treating rheumatoid arthritis pain: Cochrane systematic review
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta‐analysis
- Leflunomide for the treatment of rheumatoid arthritis
- Therapeutic ultrasound for the treatment of rheumatoid arthritis
- Muscle relaxants for pain management in rheumatoid arthritis
- Rituximab for rheumatoid arthritis
- Etanercept for the treatment of rheumatoid arthritis
- Bronchiectasis
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas
- Methotrexate for induction of remission in refractory Crohn's disease
- COVID-19 and other coronavirus infections